COVID-19 UPDATE: We are open! Our team is working and offering consultations via phone, e-mail, and video conferencing.

Zofran use during pregnancy may cause serious birth defects

Mounting lawsuits against the makers of the anti-nausea drug, Zofran allege that use during pregnancy may cause birth defects when taken during the first trimester. In addition, many very serious birth defects can occur such as cleft palate, cleft lip, and more serious complications like congenital abnormalities, thickened arteries, and fluid on the brain.

GlaxoSmithKline(GSK) are the makers of Zofran, and although the FDA has not approved the drug, they have marketed it as safe to physicians. Currently, the FDA has placed Zofran in a category B, which means there are not enough studies indicating whether or not it is safe or effective for use during pregnancy. Now there are a growing number of investigations into similar allegations of Zofran causing birth defects in unborn children.

There are also growing allegations stating animal studies, which took place in the 1980's, demonstrated that Zofran reaches past the placental barrier causing toxicity, and intrauterine deaths and malformations. Likewise, since 1992, GSK has received 200 reports of birth defects in relation to Zofran.

If you or a loved one were harmed by Zofran or any other drug, the skilled St. Louis personal injury attorneys at Meyerkord & Kurth would like to talk to you. Our experienced attorneys are currently representing Zofran cases, and can help you. Please contact us today for a free consultation.

Categories